Oncternal Therapeutics Inc (ONCT): Imbruvica (ibrutinib) Pharmacyclics (Abb...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Oncternal Therapeutics Inc (ONCT)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	80
Boards Moderated	0
Alias Born	08/12/2022

Re: None

Wednesday, 08/17/2022 9:26:36 AM

Wednesday, August 17, 2022 9:26:36 AM

Imbruvica (ibrutinib) Pharmacyclics (AbbVie) and Janssen (Johnson & Johnson)
2021 Sales $9,777,000,000.00

Data was excellent. Doubled CR of (ABBV) ibrutinib alone in MCL

Data in P53 mutant CCL is game changing

Let this sink in on how valuable this combo is $$$

Anything under $2.00 is a hell of a discount this can quadruple in price in a blink of an eye with a $60 million market cap. Smart money is accumulating for 10-20x gains next 24-36 months. ten 10 drugs in the pipeline this is a Billion dollar plus market cap in the making.

Opportunity for a take over is in the cards two ROR1 acquisitions Merck acquired early clinical data VelsoBio.. for $2.8 Billion & Boehringer buys NBE Therapeutics $1.5Billion ROR1 deal last year.

$ONCT

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ONCT News

Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 09:42:09 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:20:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:02:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:05:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:00:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:31:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:01:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:01:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 08:59:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 08:59:06 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/14/2023 08:01:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:30:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:11:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 10:59:18 PM

More ONCT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow